Table 1: Laboratory data.

WBC16700/μL(3500–9700)Influenza A-
RBC490 × 104/μL(376–516 × 104)Influenza B-
Plt28.7 × 104/μL(14.0–37.9 ×104)ANA<40(<79)
AST12 IU/L(8–38)CEA/CLIA1.1(0.0–5.0)
ALT10 IU/L(4–44)CA19–9<=1.0(0.0–37.0)
BUN4.2 mg/dL(8.0–20.0)CA12513.4(0.0–35.0)
Cr0.55 mg/dL(0.47–0.79)NSE/RIA14.8(0.1–16.3)
CPK109 IU/L(43–165)CA60210(0–63)
UA2.2 mg/dL(2.7–7.0)CSF
Na142 mEq/L(135–145)cell count185/mm3(0–15/mm3)
K4.3 mEq/L(3.5–5.0)mono168/mm3
Cl105 mEq/L(98–108)poly13/mm3
Glucose105 mg/dL(70–109)protein46 mg/dL(15–45)
CRP0.48(0.00–0.30)glucose61 mg/dL(50–75)
TSH0.39μIU/ml(0.40–4.00)HSV-PCR-
FT32.33 pg/ml(1.71–3.71)
FT41.19 ng/ml(0.70–1.48)
Serum Anti-NMDAR antibodies1:8002 months after admission
1:32004 months after admission

(), Normal range; Anti-NMDAR antibodies, Anti-N-methyl-D-aspartate receptor antibodies.